1
views
0
recommends
+1 Recommend
0 collections
    0
    shares
      • Record: found
      • Abstract: found
      • Article: found
      Is Open Access

      Corrigendum: Neurological adverse events associated with esketamine: A disproportionality analysis for signal detection leveraging the FDA adverse event reporting system

      correction

      Read this article at

      Bookmark
          There is no author summary for this article yet. Authors can add summaries to their articles on ScienceOpen to make them more accessible to a non-specialist audience.

          Related collections

          Author and article information

          Contributors
          Journal
          Front Pharmacol
          Front Pharmacol
          Front. Pharmacol.
          Frontiers in Pharmacology
          Frontiers Media S.A.
          1663-9812
          09 November 2022
          2022
          09 November 2022
          : 13
          : 1075966
          Affiliations
          [1] 1 Division of Psychopharmacology , Department of Pharmacy , The Third Hospital of Mianyang , Sichuan Mental Health Center , Mianyang, China
          [2] 2 Clinical Experimental Center , Jiangmen Central Hospital , Affiliated Jiangmen Hospital of Sun Yat-Sen University , Jiangmen, China
          [3] 3 Department of Pathology , The Third Hospital of Mianyang , Sichuan Mental Health Center , Mianyang, China
          Author notes

          Approved by: Frontiers Editorial Office, Frontiers Media SA, Switzerland

          *Correspondence: Jing Liu, ljing_syy@ 123456163.com ; Miaoquan He, hmiaoquan_syy@ 123456163.com ; Jisheng Wang, wjisheng_syy@ 123456163.com

          This article was submitted to Pharmacoepidemiology, a section of the journal Frontiers in Pharmacology

          Article
          1075966
          10.3389/fphar.2022.1075966
          9683689
          36438806
          bd7441a5-891b-4903-8ca3-2edae71da1ea
          Copyright © 2022 Guo, Wang, Yuan, Wu, Liu, He and Wang.

          This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.

          History
          : 21 October 2022
          : 24 October 2022
          Categories
          Pharmacology
          Correction

          Pharmacology & Pharmaceutical medicine
          esketamine,pharmacovigilance,neurological adverse events,signal,faers,disproportionality analysis

          Comments

          Comment on this article